TherapeuticsMD, Inc. (NYSE: TXMD) announced the launch of an underwritten public offering of $125 million of shares of its common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE